Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05564052 |
Title | A Study of Ibrutinib With Rituximab in Relapsed/Refractory Mantle Cell Lymphoma (VEGA) |
Acronym | VEGA |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Janssen Research & Development, LLC |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | TUR | SWE | ROU | POL | GRC | ESP | CZE | BRA |